Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: KIDNEY NEOPLASMS - BLOOD , . Treffer: 14
2019
Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H
Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498
Doi: 10.1097/RCT.0000000000000848
Web of Science
PubMed
FullText
FullText_MUG
2017
Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90
Doi: 10.1038/bjc.2016.393
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M
The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35
Doi: 10.1016/j.juro.2015.01.083
Web of Science
PubMed
FullText
FullText_MUG
Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551
Doi: 10.1136/jclinpath-2014-202683
Web of Science
PubMed
FullText
FullText_MUG
2014
Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC
Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536
Doi: 10.1038/bjc.2014.180
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pichler, M; Dalpiaz, O; Ehrlich, GC; Stojakovic, T; Martín Hernández, JM; Mannweiler, S; Pummer, K; Zigeuner, R; Hutterer, GC
Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
J Urol. 2014; 191(4):920-925
Doi: 10.1016/j.juro.2013.10.073
Web of Science
PubMed
FullText
FullText_MUG
2013
Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R
Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907
Doi: 10.1038/bjc.2013.28
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pichler, M; Hutterer, GC; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R
High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Br J Cancer. 2013; 109(5):1123-1129
Doi: 10.1038/bjc.2013.443
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2008
Zigeuner, R
Editorial comment on: Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Eur Urol. 2008; 54(4): 873-874.
Doi: 10.1016/j.eururo.2008.02.045
PubMed
FullText
FullText_MUG
2007
Karakiewicz, PI; Hutterer, GC; Trinh, QD; Jeldres, C; Perrotte, P; Gallina, A; Tostain, J; Patard, JJ
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
Cancer. 2007; 110(6):1241-1247
Doi: 10.1002/cncr.22896
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schips, L; Dalpiaz, O; Lipsky, K; Langner, C; Rehak, P; Puerstner, P; Pummer, K; Zigeuner, R
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Eur Urol. 2007; 51(1): 168-173.
Doi: 10.1016/j.eururo.2006.06.026
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1994
Pummer, K; Pürstner, P; Auner, HL; Stettner, H; Trummer, H; Penkoff, H; Rauchenwald, M
Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma.
Br J Urol. 1994; 73(6):612-614
Doi: 10.1111/j.1464-410X.1994.tb07543.x
Web of Science
PubMed
FullText
FullText_MUG
1993
Riccabona, M; Ring, E; Petritsch, G
Color Doppler ultrasound in differential diagnosis of unilateral congenital cystic kidney abnormalities
Z GEBURTSH PERINATOL. 1993; 197(6): 283-286.
Web of Science
PubMed
1992
Pummer, K; Wirnsberger, G; Pürstner, P; Stettner, H; Wandschneider, G
False positive prostate specific antigen values in the sera of women with renal cell carcinoma.
J Urol. 1992; 148(1):21-23
Doi: 10.1016/S0022-5347(17)36497-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar